The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois
Open Access
- 27 January 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1104828
Abstract
In December 2019, a novel pneumonic condition, Coronavirus disease 2019 (COVID- 19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), broke out in China and spread globally. The presentation of COVID-19 is more severe in persons with underlying medical conditions such as Tuberculosis (TB), Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) and other pneumonic conditions. All three diseases are of global concern and can significantly affect the lungs with characteristic cytokine storm, immunosuppression, and respiratory failure. Co-infections of SARS-CoV-2 with HIV and Mycobacterium tuberculosis (Mtb) have been reported, which may influence their pathogenesis and disease progression. Pulmonary TB and HIV/AIDS patients could be more susceptible to SARS-CoV-2 infection leading to lethal synergy and disease severity. Therefore, the biological and epidemiological interactions of COVID-19, HIV/AIDS, and TB need to be understood holistically. While data is needed to predict the impact of the COVID-19 pandemic on these existing diseases, it is necessary to review the implications of the evolving COVID-19 management on HIV/AIDS and TB control, including therapy and funding. Also, the impact of long COVID on patients, who may have this co-infection. Thus, this review highlights the implications of COVID-19, HIV/AIDS, and TB co-infection compares disease mechanisms, addresses growing concerns, and suggests a direction for improved diagnosis and general management.Keywords
This publication has 101 references indexed in Scilit:
- Modelling HIV and MTB Co-Infection Including Combined Treatment StrategiesPLOS ONE, 2012
- Tuberculosis and HIV Co-InfectionPLOS Pathogens, 2012
- Immunity and immunopathology to viruses: what decides the outcome?Nature Reviews Immunology, 2010
- Plasma cytokine levels during acute HIV-1 infection predict HIV disease progressionAIDS, 2010
- The immune response during acute HIV-1 infection: clues for vaccine developmentNature Reviews Immunology, 2009
- Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+T CellsThe Journal of Infectious Diseases, 2009
- Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsJournal of Virology, 2009
- Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infectionNature, 2005
- Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadBlood, 2004
- Severe Acute Respiratory Syndrome and Pulmonary TuberculosisClinical Infectious Diseases, 2004